Bactericidal Activity of Gentamicin against Enterococcus faecalis In Vitro and In Vivo
AUTOR(ES)
Lefort, Agnès
FONTE
American Society for Microbiology
RESUMO
The activity of gentamicin at various concentrations against two strains of Enterococcus faecalis was investigated in vitro and in a rabbit model of aortic endocarditis. In vitro, gentamicin at 0.5 to 4 times the MIC failed to reduce the number of bacteria at 24 h. Rabbit or human serum dramatically increased gentamicin activity, leading to a ≥3-log10 CFU/ml decrease in bacterial counts when the drug concentration exceeded the MIC. Susceptibility testing in the presence of serum was predictive of in vivo activity, since gentamicin alone significantly reduced the number of surviving bacteria in the vegetations if the peak-to-MIC ratio was greater than 1. However, gentamicin selected resistant mutants in rabbits. The intrinsic activity of gentamicin should be taken into account in evaluation of combinations of gentamicin and cell wall-active agents against enterococci.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=90016Documentos Relacionados
- Bactericidal activity of the fluoroquinolone WIN 57273 against high-level gentamicin-resistant Enterococcus faecalis.
- Postantibiotic effect of penicillin plus gentamicin versus Enterococcus faecalis in vitro and in vivo.
- In vitro activity of Amazon plant extracts against Enterococcus faecalis
- In vitro antimicrobial activity of acroseal, polifil and epiphany against Enterococcus faecalis
- In vitro synergism between daptomycin and fosfomycin against Enterococcus faecalis isolates with high-level gentamicin resistance.
